rs41265094
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005544.3(IRS1):āc.2452G>Cā(p.Gly818Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,613,528 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0081 ( 11 hom., cov: 33)
Exomes š: 0.012 ( 134 hom. )
Consequence
IRS1
NM_005544.3 missense
NM_005544.3 missense
Scores
1
7
10
Clinical Significance
Conservation
PhyloP100: 2.69
Genes affected
IRS1 (HGNC:6125): (insulin receptor substrate 1) This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008466393).
BP6
Variant 2-226796287-C-G is Benign according to our data. Variant chr2-226796287-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 402985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-226796287-C-G is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 1230 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRS1 | NM_005544.3 | c.2452G>C | p.Gly818Arg | missense_variant | 1/2 | ENST00000305123.6 | NP_005535.1 | |
IRS1 | XM_047444223.1 | c.2452G>C | p.Gly818Arg | missense_variant | 1/2 | XP_047300179.1 | ||
IRS1 | XM_047444224.1 | c.2452G>C | p.Gly818Arg | missense_variant | 1/2 | XP_047300180.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRS1 | ENST00000305123.6 | c.2452G>C | p.Gly818Arg | missense_variant | 1/2 | 1 | NM_005544.3 | ENSP00000304895.4 |
Frequencies
GnomAD3 genomes AF: 0.00808 AC: 1230AN: 152240Hom.: 11 Cov.: 33
GnomAD3 genomes
AF:
AC:
1230
AN:
152240
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00828 AC: 2075AN: 250672Hom.: 16 AF XY: 0.00806 AC XY: 1094AN XY: 135726
GnomAD3 exomes
AF:
AC:
2075
AN:
250672
Hom.:
AF XY:
AC XY:
1094
AN XY:
135726
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0121 AC: 17692AN: 1461170Hom.: 134 Cov.: 41 AF XY: 0.0119 AC XY: 8652AN XY: 726872
GnomAD4 exome
AF:
AC:
17692
AN:
1461170
Hom.:
Cov.:
41
AF XY:
AC XY:
8652
AN XY:
726872
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00807 AC: 1230AN: 152358Hom.: 11 Cov.: 33 AF XY: 0.00825 AC XY: 615AN XY: 74504
GnomAD4 genome
AF:
AC:
1230
AN:
152358
Hom.:
Cov.:
33
AF XY:
AC XY:
615
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
59
ALSPAC
AF:
AC:
56
ESP6500AA
AF:
AC:
14
ESP6500EA
AF:
AC:
110
ExAC
AF:
AC:
989
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | IRS1: BP4, BS1, BS2 - |
Type 2 diabetes mellitus Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | Jan 03, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Dec 17, 2014 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Has been reported in a patient with NIDDM. 2% MAF. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Uncertain
T
Polyphen
D
Vest4
MutPred
Gain of solvent accessibility (P = 6e-04);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at